New guideline on Parkinson’s disease aimed at physicians and people with Parkinson’s

New guideline on Parkinson’s disease aimed at physicians and people with Parkinson’s

Publication date: Sep 09, 2019

Credit: Wikipedia A comprehensive new Canadian guideline provides practical guidance for physicians, allied health professionals, patients and families on managing Parkinson disease, based on the latest evidence.

The new guideline, funded by Parkinson Canada, is based on the latest evidence and advances in diagnosis, treatment and symptom management, and contains a new section on palliative care.

“We hope this guideline will help physicians and other health care professionals improve the care of people with Parkinson disease,” says Dr. David Grimes, a neurologist at The Ottawa Hospital and the University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario.

In addition to its usefulness to health care professionals, the guideline may be used by policy-makers, charities and funders as well as people with Parkinson disease and their families.

“A limitation to implementing the guideline is the lack of access to health care providers experienced in caring for people with Parkinson disease,” says Dr. Grimes.

“The guideline provides evidence-based recommendations to improve the overall standard of care of individuals with Parkinson disease in Canada, not only for health care professionals, but also for policy-makers, patients themselves and their caregivers,” writes Dr. Veronica Bruno, Department of Clinical Neurosciences, Movement Disorders Program and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, and coauthor in a related commentary.

The guideline “represents a great effort to streamline the management of Parkinson disease across Canada,” they write.

Citation: New guideline on Parkinson’s disease aimed at physicians and people with Parkinson’s (2019, September 9) retrieved 9 September 2019 from This document is subject to copyright.

Concepts Keywords
Alberta Psychiatric diagnosis
Brain RTT
Brain Scanning Healthcare quality
Calgary Medical terminology
Canada Parkinson’s disease
Canadian Palliative care
Care System Medical guideline
CMAJ Dementia
Deep Brain Stimulation Physical therapy
Dementia Alpha
Depression MRI
Dopamine Aging-associated diseases
European Union Health
Fair Dealing Medicine
Gait Deep brain stimulation
Gel Depression
Hotchkiss Diagnosis Parkinson disease
Immunohistochemistry
Infographic
Infusion
Movement Disorders
MRI
Neurological
Neurologist
Ontario
Ottawa
Palliative Care
Parkinson
Parkinson Disease
Physical Therapists
Podcast
Prognosis
Progressive
Scotland
Staining
Stiffness
Substantia Nigra
Symptom
Toxin
Tremor
United Kingdom
United States

Semantics

Type Source Name
gene UNIPROT CD69
gene UNIPROT DNMT1
disease DOID Dementia
disease MESH Dementia
disease MESH depression
disease MESH drooling
disease MESH access to health care
disease MESH Movement Disorders
gene UNIPROT RXFP2
disease MESH gait
gene UNIPROT CYREN
disease DOID brain degeneration
drug DRUGBANK Dopamine
drug DRUGBANK Isoxaflutole
disease MESH tremor
disease MESH diagnosis
disease DOID Parkinson disease
disease MESH Parkinson disease
gene UNIPROT SNCA

Similar

Leave a Comment

Your email address will not be published. Required fields are marked *